Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

BioHy study initiated for treatment of osteoarthritis of the knee

Sep. 7, 1999

Hydroxamic and carboxylic acid-based MMP/TNF-alpha inhibitors center of focus at Darwin

Sep. 6, 1999

Abbott continues to improve on cell adhesion inhibitors

Sep. 6, 1999

Darwin's new MMP inhibitors useful for degenerative diseases, cancer, etc.

Sep. 3, 1999

AutoImmune reports disappointing phase III trial results for Colloral

Sep. 3, 1999

HMR and Vertex expand antiinflammatory drug discovery agreement

Sep. 3, 1999

Inhibitors of MMPs based on D-penicillamine presented by Agouron at ACS meeting

Sep. 2, 1999

p38 inhibitor RPR-200765A designated candidate for development in arthritis Rx

Sep. 1, 1999

Sulfamide inhibitors of MMPs: synthesis and pharmacological data presented at ACS meeting

Sep. 1, 1999

Inhibitors of matrix metalloproteinases reported in patent literature by American Cyanamid

Sep. 1, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...